US Drug Recall Register

FDA Drug Recalls

14,450 recalls · Class II, newest first

Class II · Moderate risk Terminated

Extended Phenytoin Sodium Capsules

Reason Failed Dissolution Specifications: Out-of-specification results for dissolution (above specification)

Amneal Pharmaceuticals of New York, LLC NDC 65162-212-10 D-0876-2023
Class II · Moderate risk Terminated

Travoprost Ophthalmic Solution

Reason Lack of Assurance of Sterility: Tamper Evidence Seal is missing on secondary container.

Golden State Medical Supply Inc. NDC 51407-731-25 D-0867-2023
Class II · Moderate risk Terminated

Levsin injection

Reason CGMP Deviations: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.

Viatris Inc NDC 0037-9001-05 D-0866-2023
Class II · Moderate risk Terminated

Sodium Chloride 0.9% Injection

Reason Lack of assurance of sterility: The product was potentially exposed to below-recommended storage temperatures, which may cause leaks in the packaging.

Fresenius Medical Care Holdings, Inc. NDC 49230-300-10 D-0777-2023
Class II · Moderate risk Completed

Pain Reliever

Reason Failed Impurities/Degradation Specifications: firm's investigation due to customer complaints for discoloration found that the product was out of specification for an impurity.

Aurobindo Pharma USA Inc. NDC 0363-9947-35 D-0765-2023
Class II · Moderate risk Ongoing

Nafcillin for Injection

Reason Lack of Assurance of Sterility

Sagent Pharmaceuticals Inc D-0764-2023
Class II · Moderate risk Ongoing

Nafcillin for Injection

Reason Lack of Assurance of Sterility

Sagent Pharmaceuticals Inc D-0763-2023
Class II · Moderate risk Ongoing

Nafcillin for Injection

Reason Lack of Assurance of Sterility

Sagent Pharmaceuticals Inc D-0762-2023
Class II · Moderate risk Terminated

Foaming Hand Sanitizer

Reason CGMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits.

Alpha Aromatics D-0760-2023
Class II · Moderate risk Terminated

Ceftriaxone for Injection

Reason Lack of Assurance of Sterility

Astral SteriTech Private Ltd. NDC 70594-098-01 D-0620-2023
Class II · Moderate risk Terminated

Ceftriaxone for Injection

Reason Lack of Assurance of Sterility

Astral SteriTech Private Ltd. NDC 70594-097-02 D-0619-2023
Class II · Moderate risk Terminated

Ceftriaxone for Injection

Reason Lack of Assurance of Sterility

Astral SteriTech Private Ltd. NDC 70594-096-02 D-0618-2023
Class II · Moderate risk Terminated

Ceftriaxone for Injection

Reason Lack of Assurance of Sterility

Astral SteriTech Private Ltd. NDC 70594-095-02 D-0617-2023